The Association Between Medication Adherence and Health-Related Quality of Life in Patients with COPD: A Cross-Sectional Study
Open accessThe DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Abstract
Purpose: Chronic obstructive pulmonary disease (COPD) is a progressive respiratory condition with debilitating manifestations that adversely affect patients' health-related quality of life (HRQoL). The clinical course is complicated by patients' low medication adherence level. Low adherence and poor HRQoL are linked to unfavorable disease outcomes. Although many factors affect adherence and HRQoL in COPD, the impact of adherence on HRQoL remain controversial. This study aimed to measure medication adherence and its impact on HRQoL in patients with COPD. Patients and Methods: This cross-sectional observational study included patients with COPD from two health centers in Riyadh, Saudi Arabia. Patients were identified using the medical database and only those fulfilling the GOLD 2020 criteria for COPD diagnosis were recruited. Data were collected via phone interviews and included sociodemographic information, the level of medication adherence assessed using the 5-item Medication Adherence Report Scale (MARS-5), and the HRQoL measured using the St. George Respiratory Questionnaire for COPD (SGRQ-C). Simple and multiple-regression analysis was used to study the factors affecting both parameters and the relation between adherence and HRQoL. Results: The mean MARS-5 score was 21.17± 4.8 (mean ± SD) with only 56.4% of patients with COPD reporting high adherence to their medications. The average total SGRQ score was 51.35 ± 23.82 indicating low HRQoL. Using multiple-regression analysis, comorbidity and intermediate disease duration were associated with lower adherence, while older age, female gender, polypharmacy, and concomitant hypertension predicted lower HRQoL. Moreover, higher adherence to medications was associated with higher overall HRQoL in patients with COPD. Conclusion: Patients with COPD have low medication adherence and low HRQoL. Several patient-, disease-, and therapy-related factors were shown to affect both outcomes; however, higher adherence to medication per se was associated with higher HRQoL in patients with COPD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additional studies from GCC settings have reported associations between reduced medication adherence and increased ED visits, poorer symptom control, and lower health-related quality of life [10,11].”
From Chronic Obstructive Pulmonary Disease in the Gulf Cooperation Council: Acute-Care Utilization and Medication Adherence: A PRISMA-ScR Scoping Review (2026) · cites this paper as [11]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“More recent evidence by Saja et al. [11] demonstrated that improved medication adherence was associated with better HRQoL outcomes among COPD patients.”
From Chronic Obstructive Pulmonary Disease in the Gulf Cooperation Council: Acute-Care Utilization and Medication Adherence: A PRISMA-ScR Scoping Review (2026) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A guideline of selecting and reporting intraclass correlation coefficients for reliability research
Koo, T. K., & Li, M. Y. (2016) · Journal of Chiropractic Medicine · doi:10.1016/j.jcm.2016.02.012 · Cited by 31,709
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
Global Initiative for Chronic Obstructive Lung Disease
Gerald, L. B., & Bailey, W. C. (2002) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200207000-00004 · Cited by 5,830
The St George's Respiratory Questionnaire
Jones, P. W., Quirk, F. H., & Baveystock, C. M. (1991) · Respiratory Medicine · doi:10.1016/s0954-6111(06)80166-6 · Cited by 2,683 · cited 1×
“40,41 Each item has a specific weight.”
DiMatteo, M. R. (2004) · Medical Care · doi:10.1097/01.mlr.0000114908.90348.f9 · Cited by 2,169
Patient Adherence and Medical Treatment Outcomes: A Meta-Analysis
Robin DiMatteo, M., Giordani, P. J., Lepper, H. S., & Croghan, T. W. (2002) · Medical Care · doi:10.1097/00005650-200209000-00009 · Cited by 1,490
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD
Mannino, D. M., Thorn, D., Swensen, A., & Holguin, F. (2008) · European Respiratory Journal · doi:10.1183/09031936.00012408 · Cited by 1,184
Quality of Life in Chronic Disease Patients
Megari, K. (2013) · Health Psychology Research · doi:10.4081/hpr.2013.932 · Cited by 895 · cited 1×
“21,22 31–33 Several factors influence medication adherence and HRQoL in COPD patients.”
(2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432601 · Cited by 830
Chan, A. H. Y., Horne, R., Hankins, M., & Chisari, C. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14193 · Cited by 523
Research works printed but not linked: 4
- Almutairi, 2015, Iran J Public Health, 44, 170
- Tóthová, 2014, Neuro Endocrinol Lett, 35, 11
- 2016, George’s Respiratory Questionnaire for COPD Patients (SGRQ-C) Manual
- Xu, 2009, Int J Tuberc Lung Dis, 13, 181
Cited by
Farhana, L., Rahayu, F. P., Sholihah, S., Sweileh, W. M., Abdulah, R., & Alfian, S. D. (2025) · Patient Preference and Adherence · doi:10.2147/ppa.s530503 · Cited by 41
Aldabayan, Y. S., Albarqi, M. N., Alamoudi, F. A., & Elsamahy, I. A. (2026) · BMC Nursing · doi:10.1186/s12912-026-04353-0 · Cited by 1
“The wider adherence literature supports this mechanism: patient–provider communication quality and therapeutic alliance are repeatedly linked to medication adherence and clinical outcomes in chronic illness, including COPD [36].”
Li, X., Ma, X., Qin, W., Shi, C., Liu, L., & Wang, C. (2026) · International Journal of COPD · doi:10.2147/copd.s589904 · Cited by 1
“12,13 Consequently, enhancing inhaler technique, adherence, and overall medication management is essential to improving prognosis.”
Elshafei, A., Safi, I., Aljoaid, A., Alanazi, O., & Almahd, S. (2026) · Healthcare · doi:10.3390/healthcare14131962
Yang, J., Xu, N., & Liang, M. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1720782
AYIK, D. B., Öner, U., Gürdap, Z., & Cengi̇z, Z. (2026) · Clinical Nursing Research · doi:10.1177/10547738261431619
“Unfortunately, adherence rates to pharmacological treatment in COPD remain alarmingly low, with studies reporting rates between 15% and 56.4% (O’Toole et al., 2022; Saja et al., 2025).”
InfluentialTesema, S. E., Muhammed, O. S., Gebremariam, G. T., Melaku, S. F., Desalew, A. F., & Tamene, F. B. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-115691
Ma, X., Li, X., Cz, S., Wang, Y., Li, W., & Liu, L. (2026) · BMJ Public Health · doi:10.1136/bmjph-2025-004558
“20 Increased medication burden, reflected in polypharmacy and regimen complexity, is often associated with poorer medication adherence.”
ÖZDEMİR, N. (2026) · Journal of Clinical Nursing · doi:10.1111/jocn.70481
“This finding is similar to some studies and is partially consistent with the literature reporting that medication adherence in patients with COPD is at a moderate level (Saja et al. 2025; Moradkhani et al. 2021).”
Erdem, G. O., Aydin, Y., & Öztürk, A. V. (2026) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph23111344
Metadata
- Authors
- Saja, M., Younis, A., Alzahrani, L., Alkhlassi, I., Aldakhil, L., Albayyat, R., Alnasser, N., Alokla, K., Alghamdi, L., Rashed, A., & Azer, S.
- Affiliations
- King Saud University (SA)
- King Fahd Medical City (SA)
- Corresponding author
- Saja, Maha
- ORCID
- Venue
- International Journal of Chronic Obstructive Pulmonary Disease
- Publisher
- Informa UK Limited
- Published
- 2025-05
- Volume
- Volume 20
- Pages
- 1567-1583
- ISSN
- 1176-9106 (ISSN-L)
- 1178-2005
- PMC
- PMC12104309
- OpenAlex
- W4410517144
- Semantic Scholar
- 6adb6e70e57e2641fef36b05b4b70dc5fb4944cb
- Cited by
- 10
- References
- 78
- Citations by year
- 2026: 9 · 2025: 1
- FWCI
- 13.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of COPD (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- chronic obstructive pulmonary disease, medication adherence, health-related quality of life, MARS-5, St George's Respiratory Questionnaire, comorbidities, disease duration, polypharmacy, hypertension, sociodemographic factors
- MeSH terms
- Aged, Bronchodilator Agents, Cross-Sectional Studies, Female, Humans, Lung, Male, Middle Aged, Quality of Life, Surveys and Questionnaires, Risk Factors, Saudi Arabia, Treatment Outcome, Polypharmacy, Pulmonary Disease, Chronic Obstructive, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.